Research accommodating lens clinical trials
Technologies such as multifocal IOLs and toric IOLs, for example, are still working their way through the real-world clinical trial that always follows FDA approval.
So far, less than 20 percent of surgeons use the former, and less than 10 percent use the latter, according to our unscientific survey (See article for more). Mike Colvard share his experience as a clinical investigator of the new lens (See article).
That's not to say they don't work or provide a benefit. If ever there were a surgeon with an admirably underdeveloped sense of hyperbole, I believe it's Dr. But you'll decide that for yourself, and I'm glad you do.